The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

BACKGROUND: Despite the availability of effective antiemetics and evidence-based guidelines, up to 40% of cancer patients receiving chemotherapy fail to achieve complete nausea and vomiting control. In addition to type of chemotherapy, several patient-related risk factors for chemotherapy-induced na...

Descripción completa

Detalles Bibliográficos
Autores principales: Dranitsaris, G., Molassiotis, A., Clemons, M., Roeland, E., Schwartzberg, L., Dielenseger, P., Jordan, K., Young, A., Aapro, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452068/
https://www.ncbi.nlm.nih.gov/pubmed/28398530
http://dx.doi.org/10.1093/annonc/mdx100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452068/
https://www.ncbi.nlm.nih.gov/pubmed/28398530
http://dx.doi.org/10.1093/annonc/mdx100

Ejemplares similares